Patents by Inventor David Tsai Ting

David Tsai Ting has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers of Cancer
    Publication number: 20220098678
    Abstract: Methods for diagnosing cancer based on detecting the presence of increased levels of expression of satellite repeats and/or Line-1.
    Type: Application
    Filed: October 8, 2021
    Publication date: March 31, 2022
    Inventors: David Tsai Ting, Daniel A. Haber, Shyamala Maheswaran, Doron Lipson
  • Biomarkers of cancer
    Patent number: 11142800
    Abstract: Methods for diagnosing cancer based on detecting the presence of increased levels of expression of satellite repeats and/or Line-1.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: October 12, 2021
    Assignee: The General Hospital Corporation
    Inventors: David Tsai Ting, Daniel A. Haber, Shyamala Maheswaran, Doron Lipson
  • Cadherins as cancer biomarkers
    Patent number: 10094837
    Abstract: Methods of isolating, enriching, capturing, identifying, or detecting the presence of, cancerous cells in a sample, e.g., a blood sample from a subject, by detecting the presence of one or more cancer cell surface markers selected from the group consisting of cadherin 1 (CDH1), CDH2, CDH3, CDH4, CDH5, CDH9, CDH11, CDH17, CDH19, protocadherin 9 (PCDH9) and/or PCDH beta 13 (PCDHb13), and optionally an additional cancer cell surface marker, e.g., EpCAM, MUC1, EphB4, EGFR, CEA, and/or HER2.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: October 9, 2018
    Assignee: The General Hospital Corporation
    Inventors: Shyamala Maheswaran, David Tsai Ting, Daniel A. Haber
  • Biomarkers of Cancer
    Publication number: 20170356054
    Abstract: Methods for diagnosing cancer based on detecting the presence of increased levels of expression of satellite repeats and/or Line-1.
    Type: Application
    Filed: May 8, 2017
    Publication date: December 14, 2017
    Inventors: David Tsai Ting, Daniel A. Haber, Shyamala Maheswaran, Doron Lipson
  • Biomarkers of Cancer
    Publication number: 20170292942
    Abstract: Methods for diagnosing cancer and monitoring treatment efficacy based on detecting the presence of increased levels of expression of satellite correlated genes.
    Type: Application
    Filed: April 25, 2017
    Publication date: October 12, 2017
    Inventors: David Tsai Ting, Shyamala Maheswaran, Daniel A. Haber
  • Cadherins as Cancer Biomarkers
    Publication number: 20160349264
    Abstract: Methods of isolating, enriching, capturing, identifying, or detecting the presence of, cancerous cells in a sample, e.g., a blood sample from a subject, by detecting the presence of one or more cancer cell surface markers selected from the group consisting of cadherin 1 (CDH1), CDH2, CDH3, CDH4, CDH5, CDH9, CDH11, CDH17, CDH19, protocadherin 9 (PCDH9) and/or PCDH beta 13 (PCDHb13), and optionally an additional cancer cell surface marker, e.g., EpCAM, MUC1, EphB4, EGFR, CEA, and/or HER2.
    Type: Application
    Filed: August 15, 2016
    Publication date: December 1, 2016
    Inventors: Shyamala Maheswaran, David Tsai Ting, Daniel A. Haber
  • Cadherins as cancer biomarkers
    Patent number: 9417244
    Abstract: Methods of isolating, enriching, capturing, identifying, or detecting the presence of, cancerous cells in a sample, e.g., a blood sample from a subject, by detecting the presence of one or more cancer cell surface markers selected from the group consisting of cadherin 1 (CDH1), CDH2, CDH3, CDH4, CDH5, CDH9, CDH11, CDH17, CDH19, protocadherin 9 (PCDH9) and/or PCDH beta 13 (PCDHb13), and optionally an additional cancer cell surface marker, e.g., EpCAM, MUC1, EphB4, EGFR, CEA, and/or HER2.
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: August 16, 2016
    Assignee: The General Hospital Corporation
    Inventors: Shyamala Maheswaran, David Tsai Ting, Daniel A. Haber
  • DIAGNOSIS OF MULTIPLE MYELOMA AND LYMPHOMA
    Publication number: 20150247205
    Abstract: The present application relates to methods for diagnosing and treating multiple myeloma (MM) and non-Hodgkin lymphoma (NHL), e.g., based on the detection of clonal IgK or IgL-expressing cells.
    Type: Application
    Filed: February 27, 2015
    Publication date: September 3, 2015
    Inventors: Manoj Gandhi, Quan Nguyen, David Tsai Ting, Miguel Rivera, Vikram Deshpande
  • Biomarkers of Cancer
    Publication number: 20140287956
    Abstract: Methods for diagnosing cancer and monitoring treatment efficacy based on detecting the presence of increased levels of expression of satellite correlated genes.
    Type: Application
    Filed: October 24, 2012
    Publication date: September 25, 2014
    Inventors: David Tsai Ting, Shyamala Maheswaran, Daniel A. Haber
  • Cadherins as Cancer Biomarkers
    Publication number: 20140234869
    Abstract: Methods of isolating, enriching, capturing, identifying, or detecting the presence of, cancerous cells in a sample, e.g., a blood sample from a subject, by detecting the presence of one or more cancer cell surface markers selected from the group consisting of cadherin 1 (CDH1), CDH2, CDH3, CDH4, CDH5, CDH9, CDH11, CDH17, CDH19, protocadherin 9 (PCDH9) and/or PCDH beta 13 (PCDHb13), and optionally an additional cancer cell surface marker, e.g., EpCAM, MUC1, EphB4, EGFR, CEA, and/or HER2.
    Type: Application
    Filed: September 28, 2012
    Publication date: August 21, 2014
    Inventors: Shyamala Maheswaran, David Tsai Ting, Daniel A. Haber
  • Biomarkers of Cancer
    Publication number: 20140031250
    Abstract: Methods for diagnosing cancer based on detecting the presence of increased levels of expression of satellite repeats and/or Line-1.
    Type: Application
    Filed: October 6, 2011
    Publication date: January 30, 2014
    Inventors: David Tsai Ting, Daniel A. Haber, Shyamala Maheswaran, Doron Lipson